Tag: Medtronic

Contact Us: 1.888.344.3434

Home          Available Breast Pumps          Support for Moms          FAQs          Why Choose EHCS         


Upgrade your Insulin Pump Before your Benefits Reset!

August 18, 2022

The MiniMed™ 770G insulin pump system automatically adjusts background insulin every 5 minutes.** Using real-time glucose readings, the system is able to calculate a personalized amount of insulin to deliver based on CGM.

Medtronic MiniMed™ 770G™ Insulin Pump System

The Medtronic MiniMed™ 770G™ insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system connects directly with a compatible smartphone, allowing you to view sugar trends and insulin delivery on the go.

Are you Eligible to Upgrade your Insulin Pump?

UPGRADE TODAY!

Ready to Upgrade?

The MiniMed™ 770G™ system gives you the flexibility to continue living your life while managing your diabetes! Sometimes referred to as a hybrid closed loop system, it automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.** This integrated system – meaning having a pump and a CGM that speak to one another – may help reduce both high and low glucose levels.**

You can even stay up-to-date on your glucose trends and insulin delivery 24/7 using the MiniMed™ Mobile app for iOS and Android. This system adapts to your unique needs, so you can focus on living your life and worrying less about managing your diabetes!

Multiple Features Make Managing Your Diabetes Easier:

  • Data-sharing capability makes virtual and in-person doctor’s appointments easier

  • Smartguard™ Auto Mode helps prevent glucose highs and lows

  • MiniMed™ Mobile App allows you to discreetly check your numbers

  • Carelink™ Connect App brings more peace of mind for care partners

  • Exercise setting may reduce lows during activities

Now may be the best time to upgrade to the 770G system, and get access to Medtronic’s MiniMed™ 780G* software upgrade at no cost, when available. Software upgrades provide the latest pump features without having to switch your physical pump!


*Investigational. Not approved by the FDA for any use and not commercially available in the US. We will let you know as soon as the software upgrade is available with the option to add our future CGM!

**Refers to SmartGuard Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 


Tags: , , , , , , ,

Related Articles

Insulin Pump Therapy: MiniMed™ 770G Pump from Medtronic

April 04, 2022

The Medtronic MiniMed™ 770G insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system automatically adjusts background insulin every 5 minutes.** By using real-time glucose readings from the integrated Guardian Connect continuous monitoring system, the system determines the amount of insulin needed based on your body’s needs.

770g pump from medtronic, medtronic 770g

See Your Sugar Levels And Insulin Delivery Right On Your Smartphone!

The MiniMed™ 770G system, sometimes referred to as a hybrid closed loop system, automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.** This integrated system – meaning having a pump and a CGM that speak to one another – may help reduce both high and low glucose levels.**

You can even stay up-to-date on your glucose trends and insulin delivery 24/7 using the MiniMed™ Mobile app for iOs and Android. This system adapts to your unique needs, so you can focus on living your life and worrying less about managing your diabetes!

Multiple Features Make Managing Your Diabetes Easier:

  • Data-sharing capability makes virtual and in-person doctor’s appointments easier

  • Smartguard™ Auto Mode helps prevent glucose highs and lows

  • MiniMed™ Mobile App allows you to discreetly check your numbers

  • Carelink™ Connect App brings more peace of mind for care partners

  • Exercise setting may reduce lows during activities

 

Learn How The MiniMed™ 770G Pump from Medtronic Can Help You Prevent Glucose Highs And Lows!

Ready to get started?

Apply Today

** Refers to SmartGuard Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

 The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

 Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 


Tags: , , , , ,

Related Articles

Benefits of a MiniMed Insulin Pump

April 04, 2022

An insulin pump is a small device that mimics the function of your pancreas by providing continuous, customized doses of insulin based on your body’s needs.

Medtronic’s selection of insulin pumps gives you the flexibility to continue living your life while managing your diabetes!

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

What is Insulin Pump Therapy?

An insulin pump is a small device that mimics the function of your pancreas by providing continuous, customized doses of insulin based on your body’s needs. Insulin pump therapy not only means 90% fewer injections*, but allows for mealtime dosing, more stable blood sugar levels, and accurate insulin delivery!

Not sure how an insulin pump works? Watch the video below!

 

Why Choose a Medtronic Insulin Pump?
Medtronic has more than 35 years of experience, over 1.2 million people living with diabetes served, and offers service and support to help you succeed with your new insulin pump therapy! Medtronic’s systems include intuitive features that help you manage your diabetes better.

SmartGuard™ Auto Mode
The MiniMed™ 670G system is the only system that automatically adjusts background insulin every five minutes based on your sugar levels.†

Benefits of the SmartGuard™ Auto Mode include:

  • Fewer highs and lows 3

  • Personalized diabetes management 3

  • More freedom to focus on your day 3, 9

  • Less effort to manage diabetes 9

Benefits of a MiniMed Insulin Pump, why use a Medtronic insulin pump

Service and Support

  • 24-Hour Technical Support to answer your questions

  • Largest support team consisting of over 2,000 field, clinical and customer care representatives

  • Personalized education and training programs

  • Dedicated insurance service teams to support your insurance needs

Exclusive CareLink™ Software

  • A web-based program that collects information directly from your Medtronic diabetes management system. It allows you to generate reports that can be used during your doctor’s visits and to monitor your own progress.

Ready to get started?

Apply Today

** Refers to SmartGuard Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

 The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

 Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 


Tags: , , , , ,

Related Articles

Insulin Pump & CGM Therapy for Children: The MiniMed™ 770G System

July 29, 2021

The Medtronic MiniMed™ 770G insulin pump system is the technology that adapts to you! Approved for ages 2 and up, this new, FDA-approved system automatically adjusts background insulin every 5 minutes.** By using real-time glucose readings from the integrated Guardian Connect continuous monitoring system, the system determines the amount of insulin needed based on your body’s needs.

770g pump from medtronic, medtronic 770g

See Your Sugar Levels And Insulin Delivery Right On Your Smartphone!

The MiniMed™ 770G system, sometimes referred to as a hybrid closed loop system, automatically adjusts delivery of basal (background) insulin based on CGM sensor glucose values. This means that the pump gets glucose readings from the CGM automatically, and then delivers a variable rate of insulin 24 hours a day based on your personal needs.** This integrated system – meaning having a pump and a CGM that speak to one another – may help reduce both high and low glucose levels.**

You can even stay up-to-date on your glucose trends and insulin delivery 24/7 using the MiniMed™ Mobile app for iOs and Android. This system adapts to your unique needs, so you can focus on living your life and worrying less about managing your diabetes!

Multiple Features Make Managing Your Diabetes Easier:

  • Data-sharing capability makes virtual and in-person doctor’s appointments easier

  • Smartguard™ Auto Mode helps prevent glucose highs and lows

  • MiniMed™ Mobile App allows you to discreetly check your numbers

  • Carelink™ Connect App brings more peace of mind for care partners

  • Exercise setting may reduce lows during activities

 

Learn How The MiniMed™ 770G Pump from Medtronic Can Help You Prevent Glucose Highs And Lows!

Learn How The MiniMed™ 770G Insulin Pump System Can Help Your Child Prevent Glucose Highs And Lows!

Ready to get started?

Apply Today

** Refers to SmartGuard Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

 The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

 Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 


Tags: , , , , ,

Related Articles

Introducing InPen, The Smart Insulin Pen

May 04, 2021

If you like the simplicity of multiple daily injection (MDI) therapy, but want the intelligence of an insulin pump, look no further than the InPen smart insulin pen system.

Finally, you can have sophisticated diabetes technology that’s easy to use – and affordable!

What is Insulin Pump Therapy?

An insulin pump is a small device that mimics the function of your pancreas by providing continuous, customized doses of insulin based on your body’s needs. Insulin pump therapy not only means 90% fewer injections*, but allows for mealtime dosing, more stable blood sugar levels, and accurate insulin delivery!

Not sure how an insulin pump works? Watch the video below!

 

Ready to get started?

Apply Today

** Refers to SmartGuard Auto Mode. Some user interaction required. Individual results may vary.

IMPORTANT SAFETY INFORMATION: MINIMED™ 770G SYSTEM WITH SMARTGUARD™ TECHNOLOGY

 The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu- Chek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

 Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety- information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library. 


Tags: , , , ,

Related Articles

Your Cart